Press Releases

Emergent BioSolutions Announces That the Final Phase II Clinical Study Results for Typhoid Vaccine Reaffirms Clinical Endpoints Met; Immune Response Seen in 97% of Treated Subjects

...

Read More

Emergent BioSolutions Announces Better-Than-Expected Preliminary 2007 Financial Results and Provides 2008 Guidance

...

Read More

Emergent BioSolutions to Present at Upcoming Investor Conferences

...

Read More

U.S. Department of Health and Human Services Remains Committed to Procurement of BioThrax(R) Under Current Contract

...

Read More

Emergent BioSolutions to Lead a United States Delegation to the United States – India Business Council (a Subsidiary of the US Chamber of Commerce) Health Summit in India

...

Read More

Emergent BioSolutions Announces Update on Department of Defense Procurement Strategy For BioThrax(R) (Anthrax Vaccine Adsorbed)

...

Read More

Emergent BioSolutions Completes Clinical Study in Support of a Post-Exposure Prophylaxis Indication for BioThrax(R) (Anthrax Vaccine Adsorbed)

...

Read More

Emergent BioSolutions Reports Financial Results for Third Quarter 2007

...

Read More

Emergent BioSolutions to Present at November Investor Conferences

...

Read More

Emergent BioSolutions to Release Third Quarter 2007 Financial Results on November 2, 2007; Management Will Conduct a Conference Call to Discuss Results as Well as Provide an Update on Business Developments

...

Read More

Emergent BioSolutions Announces Dr. Stephen Lockhart Joins Company to Lead Commercial Product Development Subsidiary

...

Read More

Emergent BioSolutions’ Typhoid Vaccine Candidate Achieves Endpoints in Phase II Clinical Study

...

Read More